Jonas J. Neher
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
IgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity.
Journal: Science advances
Published: May 13, 2026
Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 02, 2026
Non-compacted, PET-insensitive amyloid states increase after systemic inflammation and predict neuritic damage across Aβ pathology models and Alzheimer patients.
Journal: Research square
Published: February 26, 2026
Non-compacted, PET-insensitive amyloid states increase after systemic inflammation and predict neuritic damage across Aβ pathology models and Alzheimer patients.
Journal: Research square
Published: February 26, 2026
Phagocytes as Plaque Catalysts: Human Macrophages Actively Generate Pathogenic Aβ42 Fibrils with Seeding and Cross-Seeding Potency.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Soluble epoxide hydrolase drives neurovascular dysfunction in a model of amyloidosis.
Journal: Brain : a journal of neurology
Published: September 23, 2025
Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology.
Journal: Journal of neuroinflammation
Published: August 29, 2025
Medin drives Aβ40 to adopt Aβ42-like fibril polymorphs in vitro.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Atomic structures of medin and Aβ fibrils reveal polymorphic remodeling in mixed amyloid systems.
Journal: Nature communications
Published: July 25, 2025
Chimeric human organoid and mouse brain slice co-cultures to study microglial function.
Journal: Cell reports
Published: January 13, 2025
Neuroinflammation in Alzheimer disease.
Journal: Nature reviews. Immunology
Published: October 09, 2024
Last Updated: 09/26/2026